Login / Signup

Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation.

Pravin KumarErin SchexnaydreKarim RafieTatsuaki KurataIlya TereninVasili HauryliukLars-Anders Carlson
Published in: FEBS letters (2022)
Nonstructural protein 1 (Nsp1) of SARS-CoV-2 inhibits host cell translation through an interaction between its C-terminal domain and the 40S ribosome. The N-terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID-19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79-89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS-CoV-2 5' untranslated region enhances translation of mRNA, it does not protect from Nsp1-mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • single cell
  • coronavirus disease
  • cell therapy
  • stem cells
  • genome wide
  • small molecule
  • bone marrow
  • mesenchymal stem cells
  • protein protein